Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Coca-Cola Company (KO), PepsiCo, Inc. (PEP), Dr Pepper Snapple Group Inc. (DPS): Is Warren Buffett Wrong?

Warren Buffett is undoubtedly one of the best investors to ever grace the markets, but even he sometimes makes mistakes. Buffett has stated on multiple occasions that he will never — ever — sell a single share of The Coca-Cola Company (NYSE:KO). Clearly, the Oracle of Omaha believes in the durability of one of the world’s most recognizable brands.

Warren Buffett

However, though Buffett appears confident about the company’s long-term future, the picture is not as clear for us mortals. Sales volumes of soft drinks have been declining for over a decade in the United States — a key market for The Coca-Cola Company (NYSE:KO), PepsiCo, Inc. (NYSE:PEP), and Dr Pepper Snapple Group Inc. (NYSE:DPS).

Sugary soft drinks are being blamed for contributing to numerous health problems, including high blood pressure and obesity. Also, numerous studies have shown a link between soft drink consumption and heart disease, a worrying correlation that is leading more consumers to reach for water, coffee, or healthier beverages in lieu of soft drinks.

The public’s growing concern with the ill-effects of soft-drink consumption has led to a secular decline in soft-drink consumption among American consumers. Per-capita consumption of The Coca-Cola Company (NYSE:KO)’s beverages in the U.S. was lower in 2011 than it was in 2001 — a worrying trend for a region that represents 22% of case volume .

PepsiCo, Inc. (NYSE:PEP) and Dr. Pepper have experienced similar declines as well. Dr Pepper Snapple Group Inc. (NYSE:DPS) president and CEO Larry Young blamed his company’s recent 3% volume decline on “some of the coldest and wettest weather in recent years,” but weather is hardly to blame for the long-term negative trend in U.S. soft-drink sales. The real problems are increasing consumer awareness about health risks associated with the beverages and mounting attacks from state and local governments in the form of container-size constraints and excise taxes.

For instance, New York City tried to prohibit the sale of soft drinks in containers over 16 ounces. In addition, several state legislatures have debated putting a tax on sugary drinks, including a recent effort in Texas to levy a penny-per-ounce tax on the beverages. Although neither of these efforts proved to be successful — the New York law was struck down by the courts and lobbying efforts have kept state legislatures from passing onerous taxes — pressure from governments continues to mount.

What the industry must do

PepsiCo’s Frito-Lay division — the world’s largest salty-snacks business — offers the company diversification into an area in which it has a competitive advantage. Dr Pepper and The Coca-Cola Company (NYSE:KO), on the other hand, are more or less committed to the sugary beverages market. Both companies would benefit from diversifying into adjacent categories beyond sports drinks and fruit juices.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.